The CMA board will:
- ensure that the CMA fulfils its statutory duties and functions and that the principles of good corporate governance are observed
- establish the overall strategic direction of the CMA fits within the policy framework laid down under the ERR Act 2013
- have regard to any opinions and reports of the CMA Accounting Officer and ensure that the CMA makes appropriate use of public funds
The board is also responsible for:
- deciding to publish a market study notice and whether to refer a market for a phase 2 investigation
- proposals for the annual plan and consultation on the proposals
- the annual performance and concurrency reports
- making rules of procedure for merger reference groups, market reference groups, and special reference groups.
You can find more detail in The CMA board: rules of procedure.
The board consists of:
- David Currie (Chair)
- Dr Andrea Coscelli (Acting Chief Executive)
- Dr Michael Grenfell (Executive Director, Enforcement)
- Rachel Merelie (Acting Executive Director, Markets and Mergers)
- Erik Wilson (Executive Director, Corporate Services)
- Alan Giles (Non-Executive Director)
- William Kovacic (Non-Executive Director)
- Annetje Ottow (Non-Executive Director)
- Amelia Fletcher OBE (Non-Executive Director)
- Jonathan Scott (Non-Executive Director)
- Anne Lambert CMG (Panel Member Non-Executive Director)
- Sarah Chambers (Panel Member Non-Executive Director)
Members are appointed to the CMA panel by the Department for Business, Innovation and Skills for up to 8 years. They are appointed through open competition for their experience, ability and diversity of skills in competition economics, law, finance and business.
The Secretary of State for Business Innovation and Skills has designated a Chair of the CMA Panel and Deputy Chairs of the CMA Panel who are known as ‘Inquiry Chairs’ when they chair merger and market inquiries referred for phase 2 investigation by the CMA board, and regulatory appeals in relation to price controls, terms of licences or other regulatory arrangements.
More information about each of the members is available in the panel member biographies and disclosures of interest.
The CMA also has a code of conduct for panel members that sets out their general obligations.
Panel Chair and Inquiry Chair
- Professor Martin Cave OBE
- Phil Evans
- Professor Philip Marsden
- Simon Polito
- Professor Alasdair Smith
- John Wotton
- Robin Aaronson
- Lesley Ainsworth
- Marisa Cassoni
- Sarah Chambers
- Roger Finbow
- John Harley
- Rosalind Hedley-Miller
- Professor Tom Hoehn
- Katherine Holmes
- Michael Hutchings
- John Krumins
- Professor Robin Mason
- Jill May
- Tony Morris
- Malcolm Nicholson
- Stephen Oram
- Andrew Popham
- Gavin Robert
- Jayne Scott
- Graham Sharp
- Ed Smith
- Bob Spedding
- Jon Stern
- Tim Tutton
- Roger Witcomb
For any queries regarding the panel members, please email email@example.com.
Decisions on phase 2 markets and mergers work are taken by independent groups of panel members. Each group has at least 3 members and is led by a chairman.
The board’s oversight role does not extend into the substance of decisions by groups on phase 2 work. The groups make their decisions independently of the board. The board is kept informed about resourcing, efficiency, the application of CMA policy and the staff processes that support the work of the panel.